is phentermine a glp-1 receptor agonist vs Ozempic Semaglutide for Weight Loss: How

There have been few trials on the use of antiemetics such as ondansetron and aprepitant in people with severe gastroparesis

The development of dependable biomarkers to estimate therapy response and enhance patient selection constitutes another substantial unmet need, since individual responses to GLP-1 treatments might differ markedly

Individual results may vary depending on factors like diet, exercise, and more

Novo Nordisk generated more than US$ 20 billion in 2023 from its GLP-1 agonists drugs

The Australian and New Zealand College of Anaesthetists (ANZCA) and peak diabetes, obesity and gastroenterological bodies have updated recommendations, frequently asked questions (FAQs) and patient information for clinicians when talking to patients using GLP-1/GIP receptor agonists

10.1016/j.peptides.2006.05.011